What is the 13F Pro Quality Score for FTLF?

13F Pro ranks FITLIFE BRANDS, INC. (FTLF) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View FTLF's current score at https://13fpro.ai/research/FTLF (free sign-up required for the full ranking).

Where does 13F Pro source FTLF data?

All FITLIFE BRANDS, INC. fundamentals and ownership data come directly from SEC EDGAR. FITLIFE BRANDS, INC. files with the SEC under CIK 1374328. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is FTLF in?

FITLIFE BRANDS, INC. (FTLF) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is FTLF research updated on 13F Pro?

FTLF's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

FITLIFE BRANDS, INC.(FTLF)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1374328 FTLF stock profile & AI dashboard →

13F Pro Quality Score

58.0/100

Rank #1,010 of 2,879 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

80.9/100

Profitability

47.3/100

Balance Sheet

75.3/100

Earnings Quality

44.4/100

Free Cash Flow

67.3/100

Institutional Flow

33.5/100

Revenue Scale

15.3/100

Dilution Risk

94.9/100

FTLF Stock Analysis & AI Quality Score

AI stock analysis and institutional research for FITLIFE BRANDS, INC. (FTLF), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores FTLF at 58.0/100 on a 32-signal composite quality model, placing it at rank #1,010 of 2,879 stocks — the top half of the AI-ranked universe. FTLF scores in the top quartile across revenue growth (80.9), balance sheet strength (75.3). Areas of concern include revenue scale (15.3) and institutional flow (33.5), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), FITLIFE BRANDS, INC. reports quarterly revenue of $25.3M, net income of $1.7M, an operating margin of 12.1%. Top institutional holders of FTLF by reported 13-F value include BlackRock,, VANGUARD CAPITAL MANAGEMENT, HORIZON KINETICS ASSET MANAGEMENT, based on the most recent SEC filings. FTLF trades on the Nasdaq exchange and files with the SEC under CIK 1374328. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate FTLF daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for FITLIFE BRANDS, INC. directly from SEC EDGAR. FITLIFE BRANDS, INC.'s 13F Pro composite quality score has ranged between 58 and 72 since 2024, currently 58.0 — a declining long-term trajectory across 13 quarterly and live scoring snapshots.

Revenue

Q1 2026

$25.3M

Net Income

Q1 2026

$1.7M

Free Cash Flow

Q1 2026

$2.5M

Operating Margin

Q1 2026

12.1%

ROIC

Q1 2026

6.8%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+26.4% YoY

$81.5MFY 2025

FY21 $27.9MFY22 $28.8MFY24 $64.5MFY25 $81.5M

Net Income

-29.6% YoY

$6.3MFY 2025

FY21 $5.4MFY22 $4.4MFY24 $9.0MFY25 $6.3M

Operating Income

-23.3% YoY

$10.1MFY 2025

FY21 $6.2MFY22 $5.7MFY24 $13.1MFY25 $10.1M

EPS (Diluted)

-56.0% YoY

$0.20FY 2025

FY21 $0.28FY22 $0.22FY24 $0.46FY25 $0.20

Total Assets

+81.6% YoY

$106.3MFY 2025

FY21 $21.5MFY22 $25.7MFY24 $58.5MFY25 $106.3M

Total Debt

—FY 2025

FY21 —FY22 $0.00FY24 $17.6MFY25 —

Op. Cash Flow

-22.6% YoY

$7.4MFY 2025

FY21 $4.5MFY22 $4.1MFY24 $9.6MFY25 $7.4M

Metric	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020	FY 2017
Revenue	$81.5M +26.4%	$64.5M +123.8%	$28.8M +3.2%	$27.9M +28.4%	$21.7M +22.2%	$17.8M
Net Income	$6.3M -29.6%	$9.0M +102.8%	$4.4M -18.1%	$5.4M -38.7%	$8.8M +1633.8%	$509.0K
Operating Income	$10.1M -23.3%	$13.1M +130.1%	$5.7M -8.5%	$6.2M +43.4%	$4.3M +148.5%	$-9.0M
EPS (Diluted)	$0.20 -56.0%	$0.46 +104.5%	$0.22 -21.2%	$0.28 +133.1%	$0.12 +121300.0%	$-0.00
Total Assets	$106.3M +81.6%	$58.5M +127.7%	$25.7M +19.5%	$21.5M +28.2%	$16.8M +144.4%	$6.9M
Total Debt	—	$17.6M	$0.00	—	—	$2.8M
Operating Cash Flow	$7.4M -22.6%	$9.6M +132.7%	$4.1M -7.8%	$4.5M -21.7%	$5.7M +759.0%	$666.0K

AI Insight: FTLF Financial Trends

Revenue jumped 56% from Q2 2024 to Q1 2026, but profitability collapsed and cash generation stalled despite aggressive debt expansion.

• Revenue surged from $17M in Q2 2024 to $25M in Q1 2026, a 47% increase over two years.

• Operating income fell from $4M in Q2 2024 to $3M in Q1 2026 despite 47% revenue growth; operating margin compressed from 24% to 12%.

• Operating cash flow collapsed to $0M in Q4 2025, the weakest in the eight-quarter period.

⚠ Debt spiked to $61M in Q3 2025 from $13M prior quarter, then dropped off balance sheet by Q4 2025—restructuring signal.

⚠ Net income halved to $1M in Q3 2025 amid revenue spike, suggesting margin pressure and integration drag from growth.

AI Insight: FTLF Ratio Trends

Fitlife collapsed to single-digit margins in Q3 2025 before partial recovery; operating margin fell 9.6pp from Q2 2024 to TTM, signaling structural deterioration.

• Operating margin compressed from 21.7% (Q2 2024) to 12.1% (Q1 2026), a sustained 9.6pp decline over 9 quarters.

• Net profit margin fell 8.7pp from 15.5% (Q2 2024) to 6.8% (Q1 2026); Q3 2025 touched only 3.9%.

• ROIC recovered to 27.0% (Q1 2026) from Q3 2025's trough of 9.0%, but remains below the 22–34% range of 2024.

⚠ Q3 2025 saw a dramatic collapse: OpMargin fell to 9.9%, NPM to 3.9%, and ROA plummeted to 3.4%—investigate root cause.

⚠ Leverage spiked to 1.45x D/E in Q3 2025 (vs. 0.28–0.36 prior), suggesting financial stress or acquisition.

Get alerted when FTLF's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for FITLIFE BRANDS, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of FTLF

BlackRock, Inc.
$2.2M157,404 sh
VANGUARD CAPITAL MANAGEMENT LLC
$2.2M154,607 sh
HORIZON KINETICS ASSET MANAGEMENT LLC
$2.2M154,456 sh
GEODE CAPITAL MANAGEMENT, LLC
$1.2M87,677 sh
NORTHERN TRUST CORP
$760.8K53,575 sh
STATE STREET CORP
$573.5K40,385 sh
Mink Brook Asset Management LLC
$406.7K28,644 sh
VANGUARD FIDUCIARY TRUST CO
$354.2K24,942 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$333.5K23,489 sh
STIFEL FINANCIAL CORP
$283.7K19,980 sh

Fund	Value	Shares
BlackRock, Inc.	$2.2M	157,404
VANGUARD CAPITAL MANAGEMENT LLC	$2.2M	154,607
HORIZON KINETICS ASSET MANAGEMENT LLC	$2.2M	154,456
GEODE CAPITAL MANAGEMENT, LLC	$1.2M	87,677
NORTHERN TRUST CORP	$760.8K	53,575
STATE STREET CORP	$573.5K	40,385
Mink Brook Asset Management LLC	$406.7K	28,644
VANGUARD FIDUCIARY TRUST CO	$354.2K	24,942
VANGUARD PORTFOLIO MANAGEMENT LLC	$333.5K	23,489
STIFEL FINANCIAL CORP	$283.7K	19,980

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put FTLF on your watchlist

Track score changes the day FITLIFE BRANDS, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is FTLF a good stock to buy?

13F Pro's AI-powered analysis of FITLIFE BRANDS, INC. (FTLF) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for FTLF are available on the FTLF stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own FTLF?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling FTLF. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of FITLIFE BRANDS, INC.'s investment landscape.